SEC Filings | Y-mAbs Therapeutics, Inc.

Filing date	Description	Form	Filing Group	View
Sep 18, 2018	CORRESP	CORRESP	Other	0001104659-18-057437.pdf 0001104659-18-057437.rtf 0001104659-18-057437.xls View HTML
May 02, 2023	CORRESP	CORRESP	Other	0001104659-23-055096.pdf 0001104659-23-055096.rtf 0001104659-23-055096.xls View HTML
Oct 01, 2018	CT ORDER	CT ORDER	Other	9999999997-18-008036.pdf View HTML
Feb 13, 2018	Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy	DRS	Registration Statements	0000912057-18-000071.pdf 0000912057-18-000071.rtf 0000912057-18-000071.xls View HTML
Sep 20, 2018	EFFECT	EFFECT	Other	9999999995-18-002420.pdf 9999999995-18-002420.rtf 9999999995-18-002420.xls View HTML
Oct 15, 2019	EFFECT	EFFECT	Other	9999999995-19-002314.pdf 9999999995-19-002314.rtf View HTML
May 05, 2023	EFFECT	EFFECT	Other	9999999995-23-001320.pdf 9999999995-23-001320.rtf 9999999995-23-001320.xls View HTML
Jun 02, 2021	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	144	Other	0001104659-21-075746.pdf 0001104659-21-075746.rtf 0001104659-21-075746.xls View HTML
Nov 20, 2023	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	144	Other	0001968582-23-000679.pdf 0001968582-23-000679.rtf View HTML
Dec 13, 2023	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	144	Other	0001968582-23-000768.pdf 0001968582-23-000768.rtf 0001968582-23-000768.xls View HTML

Data provided by Kaleidoscope.